U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
IMMUNOGLOBULIN G1, ANTI-(HUMAN PROGRAMMED DEATH-LIGAND 1) (HUMAN MONOCLONAL LDP .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LDP .KAPPA.-CHAIN, DIMER
Preferred Name English
LESABELIMAB
INN  
Official Name English
lesabelimab [INN]
Common Name English
Code System Code Type Description
SMS_ID
300000049565
Created by admin on Wed Apr 02 10:20:34 GMT 2025 , Edited by admin on Wed Apr 02 10:20:34 GMT 2025
PRIMARY
FDA UNII
R8ZW84Q6SU
Created by admin on Wed Apr 02 10:20:34 GMT 2025 , Edited by admin on Wed Apr 02 10:20:34 GMT 2025
PRIMARY
NCI_THESAURUS
C203035
Created by admin on Wed Apr 02 10:20:34 GMT 2025 , Edited by admin on Wed Apr 02 10:20:34 GMT 2025
PRIMARY
INN
11914
Created by admin on Wed Apr 02 10:20:34 GMT 2025 , Edited by admin on Wed Apr 02 10:20:34 GMT 2025
PRIMARY
CAS
2475402-56-1
Created by admin on Wed Apr 02 10:20:34 GMT 2025 , Edited by admin on Wed Apr 02 10:20:34 GMT 2025
PRIMARY
SUBSTANCE RECORD
LESABELIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966